Company Overview of Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. operates as a biotechnology company that engages in the discovery and development of ‘orally stable peptides’ against validated targets and diseases that are being addressed by ‘injectable biologics’. The company focuses on developing oral peptides for inflammatory bowel diseases (IBD), irritable bowel syndrome, and other gastro-intestinal disorders. Its development portfolio includes a4ß7 integrin specific ‘oral peptide’ antagonist for the treatment of IBD; IL-6 peptide antagonist, which is used in the treatment of various diseases, such as IBD, psoriasis, and rheumatoid arthritis; Hepcidin, a natural peptide hormone that regulates iron homeostasis and its def...
521 Cottonwood Drive
Milpitas, CA 95035-7404
Founded in 2001
Key Executives for Protagonist Therapeutics, Inc.
Founder and Vice President of Technology & Alliances
Senior Vice President of Corporate Development
Senior Director of Preclinical Development
Compensation as of Fiscal Year 2014.
Protagonist Therapeutics, Inc. Key Developments
Protagonist Therapeutics Appoints Chaitan Khosla to Board of Directors
Nov 5 14
Protagonist Therapeutics, Inc. announced that Chaitan Khosla, Ph.D., founder of Alvine Pharmaceuticals and Kosan Biosciences (now part of Bristol-Myers Squibb), Director of Stanford ChEM-H, and Stanford University Professor in the Departments of Chemistry and Chemical Engineering, has been elected to the Protagonist Board of Directors.
Protagonist Therapeutics, Inc. Presents at 13th Annual BIO Investor Forum, Oct-07-2014 10:30 AM
Aug 6 14
Protagonist Therapeutics, Inc. Presents at 13th Annual BIO Investor Forum, Oct-07-2014 10:30 AM. Venue: The Palace Hotel, San Francisco, CA 94105, United States.
Protagonist Therapeutics, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 03:00 PM
Feb 11 14
Protagonist Therapeutics, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 03:00 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|